GlassScriptPhysician profile
David Evan Surrey
NPI 1912343666
$784.45
in general payments reported to CMS, 2019-2025
9 companies · $29.49 in 2025
The $29.49 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.60 · 2020: $16.28 · 2021: $169 · 2022: $181 · 2023: $262 · 2024: $71.86 · 2025: $29.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $367.90 | 2019-2023 | |
| Bioventus LLC | $185.32 | 2020-2025 | Durolane |
| Zimmer Biomet Holdings, INC. | $68.81 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Davol INC. | $45.89 | 2023 | Arista Ah Flexitip |
| Si-Bone, INC. | $43.63 | 2022 | |
| Ethicon US, LLC | $32.55 | 2022 | |
| Depuy Synthes Sales INC. | $17.37 | 2024 | Monovisc, Orthovisc |
| Vertical Pharmaceuticals, LLC | $12.12 | 2019 | |
| Ermi LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Surrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.